Take a look at some of the biggest movers in the premarket:

Johnson & Johnson (JNJ) – J&J said a batch of its Covid-19 vaccine that came from a Baltimore factory did not meet quality standards and will not be distributed. The company said the problem stemmed from a quality issue for a vaccine ingredient made by Emergent BioSolutions (EBS). J&J fell 1.1% premarket, while Emergent BioSolutions tumbled 8.5%.